Aiken Abigail R A, Trussell James
Office of Population Research, Wallace Hall, Princeton University Princeton, NJ 08544 USA.
F1000Prime Rep. 2014 Dec 1;6:113. doi: 10.12703/P6-113. eCollection 2014.
Focusing on intrauterine contraceptives (IUC), contraceptive implants, and emergency contraceptives, we review recent advances in contraceptive development and discuss progress in policies to improve access to the most effective methods. We report on the shift in practice towards routinely providing IUCs and implants to young and nulliparous women, prompted in part by the reduced diameter of the insertion tube for the Mirena IUC and the development of a smaller IUC called Skyla. Additionally, we describe the new SCu300A intrauterine ball and the development of an implant called Nexplanon, which comes with a preloaded inserter. We also discuss the efficacy of ulipristal acetate versus levonorgestrel for emergency contraception, especially for women who weigh more than 75 kg. Finally, in light of the increasing interest in providing IUCs and implants to women in the immediate postpartum and post-abortion periods, we consider the rationale for this change in practice and review the progress that has been made so far in the United States.
聚焦于宫内节育器(IUC)、避孕植入剂和紧急避孕药,我们回顾了避孕技术发展的最新进展,并讨论了改善获取最有效避孕方法的政策进展。我们报告了实践中的转变,即常规为年轻未育女性提供宫内节育器和植入剂,这部分是由于曼月乐宫内节育器插入管直径减小以及一种名为斯凯拉的更小宫内节育器的研发。此外,我们描述了新型SCu300A宫内节育球以及一种名为依伴侬的植入剂的研发情况,依伴侬配有预装插入器。我们还讨论了醋酸乌利司他与左炔诺孕酮用于紧急避孕的效果,特别是对于体重超过75公斤的女性。最后,鉴于在产后和流产后立即为女性提供宫内节育器和植入剂的兴趣日益浓厚,我们考虑了这种实践变化的基本原理,并回顾了美国到目前为止所取得的进展。